Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT05368818
Status:
COMPLETED
Last Update Posted:
2022-07-01
First Post:
2022-05-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data Source
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-06
Completion Date Type:
ACTUAL
First Submit Date:
2022-05-05
First Submit QC Date:
None
Study First Post Date:
2022-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-29
Last Update Post Date:
2022-07-01
Last Update Post Date Type:
ACTUAL